Improvement of embryonic stem cell line derivation efficiency with novel medium, glucose concentration, and epigenetic modifications

Cloning and Stem Cells

Volumn 11, Issue 1, 2009, Pages 89-99

  Kim, Chul ^a   Amano, Tomokazu ^a   Park, Joonghoon ^a   Carter, Mark G ^a   Tian, Xiuchun ^a   Yang, Xiangzhong ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GLUCOSE; OCTAMER TRANSCRIPTION FACTOR 4; TRICHOSTATIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLASTOCYST; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DNA MODIFICATION; EMBRYO; EMBRYO CULTURE; EMBRYONIC STEM CELL; EPIGENETICS; FEMALE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLASTOCYST; CELL CULTURE TECHNIQUES; CULTURE MEDIA; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION; GLUCOSE; HOMEODOMAIN PROTEINS; MICE; OCTAMER TRANSCRIPTION FACTOR-3; SOXB1 TRANSCRIPTION FACTORS;

EID: 62349089853     PISSN: 15362302     EISSN: None     Source Type: Journal    
DOI: 10.1089/clo.2008.0053     Document Type: Article

References (56)

1. Abbondanzo SJ, Gadi I, Stewart CL. (1993). Derivation of embryonic stem cell lines. Methods Enzymol. 225:803-823.
2. Amano T, Gertsenstein M, Nagy A, et al. (2006). Nuclear transfer reprogramming does not improve the low developmental potency of embryonic stem cells induced by long-term culture. Reproduction 132, 257-263.
3. Amit M, Carpenter MK, Inokuma MS, et al. (2000). Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271-278.
4. Boiani M, Eckardt S, Scholer HR, et al. (2002). Oct4 distribution and level in mouse clones: consequences for pluripotency. Genes Dev. 16, 1209-1219.
5. Bongso A, Fong CY, Ng SC, et al. (1994). Isolation and culture of inner cell mass cells from human blastocysts. Hum. Reprod. 9, 2110-2117.
6. Bradley A, Evans M, Kaufman MH, et al. (1984). Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255-256.
7. Brook FA, Gardner RL. (1997). The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. USA 94, 5709-5712.
8. Bryja V, Bonilla S, Arenas E. (2006). Derivation of mouse embryonic stem cells. Nat Protoc. 1:2082-2087.
9. Carlone DL, Lee JH, Young SR, et al. (2005). Reduced genomic cytosine methylation and defective cellular differentiation in embryonic stem cells lacking CpG binding protein. Mol. Cell Biol. 25, 4881-4891.
10. Chapman V, Forrester L, Sanford J, et al. (1984). Cell lineage-specific undermethylation of mouse repetitive DNA. Nature 307, 284-286.
11. Ding X, Wang Y, Zhang D, et al. (2008). Increased pre-implantation development of cloned bovine embryos treated with 5-aza-2′-deoxycytidine and trichostatin A. Theriogenology 70, 622-630.
12. Enright BP, Kubota C, Yang X, et al. (2003). Epigenetic characteristics and development of embryos cloned from donor cells treated by trichostatin A or 5-aza-2′-deoxycytidine. Biol. Reprod. 69:896-901.
13. Evans MJ, Kaufman MH. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156.
14. Gao S, Latham KE. (2004). Maternal and environmental factors in early cloned embryo development. Cytogenet. Genome Res. 105, 279-284.
15. Hattori N, Nishino K, Ko YG, et al. (2004). Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J. Biol. Chem. 279, 17063-17069.
16. Heilig C, Brosius F, Siu B, et al. (2003). Implications of glucose transporter protein type 1 (GLUT1)-haplodeficiency in embryonic stem cells for their survival in response to hypoxic stress. Am. J. Pathol. 163, 1873-1885.
17. Hessle L, Johnson KA, Anderson HC, et al. (2002). Tissue-non-specific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc. Natl. Acad. Sci. USA 99, 9445-9449.
18. Huangfu D, Maehr R, Guo W, et al. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol. 26, 795-797.
19. Huebert DJ, Bernstein BE. (2005). Genomic views of chromatin. Curr. Opin. Genet. Dev. 15, 476-481.
20. Ishiwata I, Tokeida Y, Iguchi M, et al. (2001). New approach for the establishment of mouse early embryonic stem cells and induction of their differentiation. Hum. Cell 14:283-291.
21. Ishizaka S, Shiroi A, Kanda S, et al. (2002). Development of hepatocytes from ES cells after transfection with the HNF-3beta gene. FASEB J. 16:1444-1446.
22. Jo YY, Lee HJ, Kook SY, et al. (2007). Isolation and characterization of postnatal stem cells from human dental tissues. Tissue Eng. 13:767-773.
23. Kawase E, Suemori H, Takahashi N, et al. (1994). Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int. J. Dev. Biol. 38:385-390.
24. Kim JM, Liu H, Tazaki M, et al. (2003). Changes in histone acetylation during mouse oocyte meiosis. J. Cell Biol. 162:37-46.
25. Kim YH, Han HJ. (2008). High-glucose-induced prostaglandin E(2) and peroxisome proliferator-activated receptor delta promote mouse embryonic stem cell proliferation. Stem Cells 26, 745-755.
26. Kim YH, Heo JS, Han HJ. (2006). High glucose increase cell cycle regulatory proteins level of mouse embryonic stem cells via PI3-K/Akt and MAPKs signal pathways. J. Cell Physiol. 209, 94-102.
27. Kishigami S, Mizutani E, Ohta H, et al. (2006). Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer. Biochem. Biophys. Res. Commun. 340, 183-189.
28. Lee JH, Hart SR, Skalnik DG. (2004). Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 38:32-38.
29. Leunda-Casi A, Genicot G, Donnay I, et al. (2002). Increased cell death in mouse blastocysts exposed to high D-glucose in vitro: implications of an oxidative stress and alterations in glucose metabolism. Diabetologia 45, 571-579.
30. Li E. (2002). Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 3, 662-673.
31. Martin GR. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78, 7634-7638.
32. Masui S, Nakatake Y, Toyooka Y, et al. (2007). Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9, 625-635.
33. McWhir J, Schnieke AE, Ansell R, et al. (1996). Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background. Nat. Genet. 14:223-226.
34. Mikkelsen TS, Hanna J, Zhang X, et al. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55.
35. Mitalipova M, Beyhan Z, First NL. (2001). Pluripotency of bovine embryonic cell line derived from precompacting embryos. Cloning 3, 59-67.
36. Mitsui K, Tokuzawa Y, Itoh H, et al. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642.
37. Miura T, Mattson MP, Rao MS. (2004). Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 3, 333-343.
38. Moley KH, Chi MM, Knudson CM, et al. (1998). Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat. Med. 4, 1421-1424.
39. Nichols J, Zevnik B, Anastassiadis K, et al. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391.
40. Paquin J, Danalache BA, Jankowski M, et al. (2002). Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc. Natl. Acad. Sci. USA 99, 9550-9555.
41. Pease S, Braghetta P, Gearing D, et al. (1990). Isolation of embryonic stem (ES) cells in media supplemented with recombinant leukemia inhibitory factor (LIF). Dev. Biol. 141, 344-352.
42. Poueymirou WT, Conover JC, Schultz RM. (1989). Regulation of mouse preimplantation development: differential effects of CZB medium and Whitten's medium on rates and patterns of protein synthesis in 2-cell embryos. Biol. Reprod. 41, 317-322.
43. Reik W, Dean W, Walter J. (2001). Epigenetic reprogramming in mammalian development. Science 293, 1089-1093.
44. Roach ML, McNeish JD. (2002). Methods for the isolation and maintenance of murine embryonic stem cells. Methods Mol. Biol. 185, 1-16.
45. Santos F, Hendrich B, Reik W, et al. (2002). Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev. Biol. 241, 172-182.
46. Scholer HR, Hatzopoulos AK, Balling R, et al. (1989). A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J. 8, 2543-2550.
47. Schoonjans L, Kreemers V, Danloy S, et al. (2003). Improved generation of germline-competent embryonic stem cell lines from inbred mouse strains. Stem Cells 21, 90-97.
48. Solter D, Knowles BB. (1978). Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc. Natl. Acad. Sci. USA 75, 5565-5569.
49. Suzuki H, Togashi M, Adachi J, et al. (1995). Developmental ability of zona-free mouse embryos is influenced by cell association at the 4-cell stage. Biol. Reprod. 53, 78-83.
50. Taranger CK, Noer A, Sorensen AL, et al. (2005). Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol. Biol. Cell 16, 5719-5735.
51. Thomson JA, Kalishman J, Golos TG, et al. (1995). Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. USA 92, 7844-7848.
52. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
53. Tsuji-Takayama K, Inoue T, Ijiri Y, et al. (2004). Demethylating agent, 5-azacytidine, reverses differentiation of embryonic stem cells. Biochem. Biophys. Res. Commun. 323, 86-90.
54. Wang F, Thirumangalathu S, Loeken MR. (2006). Establishment of new mouse embryonic stem cell lines is improved by physiological glucose and oxygen. Cloning Stem Cells 8, 108-116.
55. Williams RL, Hilton DJ, Pease S, et al. (1988). Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684-687.
56. Wobus AM, Holzhausen H, Jakel P, et al. (1984). Characterization of a pluripotent stem cell line derived from a mouse embryo. Exp. Cell Res. 152, 212-219.